Responses of carbapenemase-producing and non-producing carbapenem-resistant Pseudomonas aeruginosa strains to meropenem revealed by quantitative tandem mass spectrometry proteomics

被引:4
|
作者
Salva-Serra, Francisco [1 ,2 ,3 ,4 ,5 ,6 ]
Jaen-Luchoro, Daniel [1 ,3 ,4 ,5 ]
Marathe, Nachiket P. [7 ]
Adlerberth, Ingegerd [1 ,2 ,5 ]
Moore, Edward R. B. [1 ,2 ,3 ,4 ,5 ]
Karlsson, Roger [1 ,2 ,5 ,8 ]
机构
[1] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden
[3] Univ Gothenburg, Culture Collect Univ Gothenburg CCUG, Sahlgrenska Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden
[5] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden
[6] Univ Balearic Isl, Dept Biol, Microbiol, Palma de Mallorca, Spain
[7] Inst Marine Res IMR, Bergen, Norway
[8] Nanoxis Consulting AB, Gothenburg, Sweden
关键词
Pseudomonas aeruginosa; carbapenem-resistance; multidrug resistance; nano-LC-MS; MS; tandem mass tag; quantitative shotgun proteomics; extensively-drug resistant; high-risk clones; PENICILLIN-BINDING PROTEINS; BETA-LACTAM ANTIBIOTICS; VI SECRETION; GENOME SEQUENCE; SIGMA-FACTOR; ANTIBACTERIAL ACTIVITY; FUNCTIONAL GENOMICS; CYSTIC-FIBROSIS; WEB SERVER; CD-HIT;
D O I
10.3389/fmicb.2022.1089140
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa is an opportunistic pathogen with increasing incidence of multidrug-resistant strains, including resistance to last-resort antibiotics, such as carbapenems. Resistances are often due to complex interplays of natural and acquired resistance mechanisms that are enhanced by its large regulatory network. This study describes the proteomic responses of two carbapenem-resistant P. aeruginosa strains of high-risk clones ST235 and ST395 to subminimal inhibitory concentrations (sub-MICs) of meropenem by identifying differentially regulated proteins and pathways. Strain CCUG 51971 carries a VIM-4 metallo-beta-lactamase or 'classical' carbapenemase; strain CCUG 70744 carries no known acquired carbapenem-resistance genes and exhibits 'non-classical' carbapenem-resistance. Strains were cultivated with different sub-MICs of meropenem and analyzed, using quantitative shotgun proteomics based on tandem mass tag (TMT) isobaric labeling, nano-liquid chromatography tandem-mass spectrometry and complete genome sequences. Exposure of strains to sub-MICs of meropenem resulted in hundreds of differentially regulated proteins, including beta-lactamases, proteins associated with transport, peptidoglycan metabolism, cell wall organization, and regulatory proteins. Strain CCUG 51971 showed upregulation of intrinsic beta-lactamases and VIM-4 carbapenemase, while CCUG 70744 exhibited a combination of upregulated intrinsic beta-lactamases, efflux pumps, penicillin-binding proteins and downregulation of porins. All components of the H1 type VI secretion system were upregulated in strain CCUG 51971. Multiple metabolic pathways were affected in both strains. Sub-MICs of meropenem cause marked changes in the proteomes of carbapenem-resistant strains of P. aeruginosa exhibiting different resistance mechanisms, involving a wide range of proteins, many uncharacterized, which might play a role in the susceptibility of P. aeruginosa to meropenem.
引用
收藏
页数:37
相关论文
共 26 条
  • [1] Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
    Tamma, Pranita D.
    Huang, Yanjie
    Opene, Belita N. A.
    Simner, Patricia J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6425 - 6429
  • [2] Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae
    Marimuthu, Kalisvar
    Ng, Oon Tek
    Cherng, Benjamin Pei Zhi
    Fong, Raymond Kok Choon
    Pada, Surinder Kaur
    De, Partha Pratim
    Ooi, Say Tat
    Smitasin, Nares
    Thoon, Koh Cheng
    Krishnan, Prabha Unny
    Ang, Michelle Lay Teng
    Chan, Douglas Su Gin
    Kwa, Andrea Lay Hoon
    Deepak, Rama Narayana
    Chan, Yu Kit
    Chan, Yvonne Fu Zi
    Huan, Xiaowei
    Linn, Kyaw Zaw
    Tee, Nancy Wen Sim
    Tan, Thean Yen
    Koh, Tse Hsien
    Lin, Raymond Tzer Pin
    Hsu, Li Yang
    Sengupta, Sharmila
    Paterson, David L.
    Perencevich, Eli
    Harbarth, Stephan
    Teo, Jeanette
    Venkatachalam, Indumathi
    Cherng, Benjamin
    Gin, Douglas Chan Su
    Narayana, Deepak Rama
    Pratim, De Partha
    Yang, Hsu Li
    Venkatacha, Indumathi
    Hsien, Koh Tse
    Tee, Nancy
    Tek, Ng Oon
    Tat, Ooi Say
    Fong, Raymond
    Pin, Raymond Lin Tzer
    Yen, Tan Thean
    Cheng, Thoon Koh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)
  • [3] Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
    Tamma, Pranita D.
    Goodman, Katherine E.
    Harris, Anthony D.
    Tekle, Tsigereda
    Roberts, Ava
    Taiwo, Abimbola
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 257 - 264
  • [4] In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains
    Hagihara, Mao
    Kato, Hideo
    Yamashita, Rieko fff
    Soda, Midori
    Watanabe, Hiroki
    Sakanashi, Daisuke
    Shiota, Arufumi
    Asai, Nobuhiro
    Koizumi, Yusuke
    Suematsu, Hiroyuki
    Yamagishi, Yuka
    Kitaichi, Kiyoyuki
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (01) : 1 - 7
  • [5] Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa
    Lee, Su Young
    Gill, Christian M.
    Nicolau, David P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (12) : 2795 - 2800
  • [6] Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii
    Antonio Martinez, Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 : 31 - 34
  • [7] Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms
    Wi, Yu Mi
    Greenwood-Quaintance, Kerryl E.
    Schuetz, Audrey N.
    Ko, Kwan Soo
    Peck, Kyong Ran
    Song, Jae-Hoon
    Patel, Robin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [8] Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization
    Gill, Christian M.
    Aktas, Elif
    Alfouzan, Wadha
    Bourassa, Lori
    Brink, Adrian
    Burnham, Carey-Ann D.
    Canton, Rafael
    Carmeli, Yehuda
    Falcone, Marco
    Kiffer, Carlos
    Marchese, Anna
    Martinez, Octavio
    Pournaras, Spyros
    Seifert, Harald
    Thabit, Abrar K.
    Virginia Villegas, Maria
    Westblade, Lars F.
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (11)
  • [9] Cluster of Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Among Patients in an Adult Intensive Care Unit-Idaho, 2021-2022
    Cahill, Megan E.
    Jaworski, Martha
    Harcy, Victoria
    Young, Erin
    Ham, D. Cal
    Gable, Paige
    Carter, Kris K.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (31): : 844 - 846
  • [10] Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae
    Hayakawa, Kayoko
    Nakano, Ryuichi
    Hase, Ryota
    Shimatani, Michitsugu
    Kato, Hideaki
    Hasumi, Jumpei
    Doi, Asako
    Sekiya, Noritaka
    Nei, Takahito
    Okinaka, Keiji
    Kasahara, Kei
    Kurai, Hanako
    Nagashima, Maki
    Miyoshi-Akiyama, Tohru
    Kakuta, Risako
    Yano, Hisakazu
    Ohmagari, Norio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 697 - 708